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Abstract Chlorpromazine (CPZ) is a small permeable
cationic amphiphilic molecule that inserts into membrane
bilayers and binds to anionic lipids such as poly-phosphoi-
nositides (PIs). Since PIs play important roles in many cel-
lular processes, including signaling and membrane
traYcking pathways, it has been proposed that CPZ aVects
cellular growth functions by preventing the recruitment of
proteins with speciWc PI-binding domains. In this study, we
have investigated the biological eVects of CPZ in the yeast
Saccharomyces cerevisiae. We screened a collection of
approximately 4,800 gene knockout mutants, and found
that mutants defective in membrane traYcking between the
late-Golgi and endosomal compartments are highly sensi-
tive to CPZ. Microscopy and transport analyses revealed
that CPZ aVects membrane structure of organelles, blocks
membrane transport and activates the unfolded protein
response (UPR). In addition, CPZ-treatment induces phos-
phorylation of the translation initiation factor (eIF2),
which reduces the general rate of protein synthesis and
stimulates the production of Gcn4p, a major transcription
factor that is activated in response to environmental
stresses. Altogether, our results reveal that membrane stress
within the cells rapidly activates an important gene expres-
sion program, which is followed by a general inhibition of
protein synthesis. Remarkably, the increase of phosphory-
lated eIF2 and protein synthesis inhibition were also
detected in CPZ-treated NIH-3T3 Wbroblasts, suggesting
the existence of a conserved mechanism of translational
regulation that operates during a membrane stress.
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Abbreviations
CPZ Chlorpromazine
Tm Tunicamycin
3-AT 3-Aminotriazole
UPR Unfolded protein response
ER Endoplasmic reticulum
PI Phosphoinositide
PS Phosphatidylserine
PA Phosphatidylamine
PE Phosphatidylethanolamine
Introduction
Control of gene expression at the level of mRNA transla-
tion is the most immediate response to environmental or
cellular stresses (Dever 1999). This regulation involves the
phosphorylation of the  subunit of the translation initiation
factor eIF2 (Dever et al. 1992). Phosphorylated eIF2
(eIF2-P) causes a rapid decrease of global translation initi-
ation by reducing the activity of the eIF2 complex. eIF2 is
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tRNA (Met-tRNAiMet) to the small (40S) ribosomal sub-
unit in the Wrst step of translation initiation. In mammalian
cells, phosphorylation of eIF2 is mediated by four diVer-
ent protein kinases (PKR, HRI, GCN2 and PERK), which
are activated in response to diVerent cellular stresses such
as a viral infection, heme deWciency in erythrocytes, nutri-
ent starvation and accumulation of unfolded proteins in the
ER [reviewed in Holcik and Sonenberg (2005)]. Gcn2p, the
only eIF2 kinase in yeast, is activated upon depletion of
any amino acid by binding the corresponding uncharged
tRNA at its regulatory C-terminal domain, which is related
to the histidyl-tRNA synthetase (HisRS) (reviewed in Hin-
nebusch 2005). In addition to inhibiting translation initia-
tion of almost all mRNAs, eIF2-P activates the expression
of Gcn4p by a unique translational control mechanism
(reviewed in Hinnebusch 2005). Gcn4p is the major tran-
scriptional activator of amino acid biosynthetic genes that
is activated under amino acid starvation (Natarajan et al.
2001), a cellular response named general amino acid con-
trol (GAAC).
Gcn2p activity is also induced by other environmental
stresses, which all elicit the increase of Gcn4p expression
(Cherkasova and Hinnebusch 2003). These Wndings have
led to the hypothesis that Gcn4p is capable of responding to
diVerent stresses, and therefore functions in more than one
transcriptional gene expression program. Notably, Patil
et al. (2004) showed that Gcn4p also regulates the expres-
sion of genes that are unrelated to the activation of GAAC
genes but are part of the unfolded protein response (UPR).
The UPR is triggered by the accumulation of unfolded pro-
teins in the ER and leads to the activation of the ER-resi-
dent transmembrane kinase/endoribonuclease Ire1p (Cox
et al. 1993). The activated Ire1p catalyzes a nonconven-
tional splicing reaction that governs the production of the
transcription factor Hac1p. Hac1p was shown to associate
with Gcn4p to bind to upstream activation sequences found
in the promoters of some UPR target genes (Patil et al.
2004), thus allowing a transcriptional response to ER stress.
Recently, Chang et al. (2004) showed that the UPR is
also activated after a partial membrane transport defect
anywhere along the secretory pathway. Notably, the activa-
tion of the UPR alleviates the impairment of protein trans-
port and partially suppresses the growth defect of sec
mutants. Additionally, Leber et al. (2004) reported that a
block of the secretory pathway leads to a pronounced
increase of HAC1 mRNA production, deWning another
mechanism of UPR control (termed S-UPR), which oper-
ates at the transcriptional level. These Wndings demonstrate
that cells respond to a block of membrane transport to the
cell surface by inducing a speciWc transcriptional program.
In this context, we previously showed, using either sec
mutants or chlorpromazine (CPZ), that eIF2 phosphoryla-
tion is strongly induced upon a membrane stress (Deloche
et al. 2004). Thus, the expression of Hac1p and Gcn4p may
be required to induce an appropriate cellular response that
enables cells to cope with a membrane transport defect.
In this study, we investigated the toxic membrane eVects
of CPZ on actively growing Saccharomyces cerevisiae
cells. CPZ is an antipsychotic drug historically used in the
treatment of schizophrenia that blocks the activity of vari-
ous neurophysiological receptors such as dopamine and
serotonin receptors (Capuano et al. 2002; Trichard et al.
1998). Although CPZ was shown to directly bind to some
of these receptors, recent works indicate that the diverse
eVects of CPZ are mostly attributable to its interaction with
anionic lipids (Chen et al. 2003; Jutila et al. 2001). Here,
we report that CPZ profoundly perturbs membrane proper-
ties of internal organelles and leads to a rapid translational
control of gene expression.
Materials and methods
Strains, reagents and growth conditions
Yeast strains used for the study are shown in Table 1, and
their construction is described below. Strains were grown in
standard rich medium (yeast extract-peptone-dextrose,
YPD) or in synthetic complete medium complemented with
2% dextrose (SD) and the appropriate amino acids for plas-
mid maintenance (Guthrie and Fink 1991). NIH-3T3 cells
were maintained in DMEM supplemented with 10% fetal
calf serum (GIBCO Life Science). Chlorpromazine, tunica-
mycin, 3-aminotriazole and thapsigargin were purchased
from Sigma. Rapamycin was obtained from LC Laborato-
ries. All these chemical products were prepared as recom-
mended by the manufacturers.
The ODY304 (sec7::SEC7-EGFPx3::URA3) strain was
constructed by pop-in-pop-out replacement with SEC7-
EGFP as described in (Rossanese et al. 2001). Strains
ODY326 and ODY327 were obtained by plasmid shuZing
on 5-FOA plate using plasmids p[SUI2, LEU2; CEN] and
p[sui2S51A, LEU2; CEN], respectively from the H1647
parental strain (25).
Chemical genomic screening analysis
The screen was performed using sublethal concentrations
(10 and 20 M) of CPZ in YPD medium buVered at pH 8.0
with 20 mM Tris–HCl pH 9.4. The EUROSCARF yeast
deletion library (4,855 clones) and the parental strains
BY4741 and BY4742 were replicated (in duplicate) on
YPD plates at pH 8.0 containing 0, 10 and 20 M CPZ.
Cells were then incubated at 30°C and growth phenotypes
were recorded after 2 days. Mutants with a no (¡) or slow123
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identiWed using the Saccharomyces Genome Database and
the MIPS Comprehensive Yeast Genome Database
(CYGD) and listed in Table 2.
Electron microscopy
Early log-phase cells were grown in YPD (approximately
50 OD600 units), harvested, and Wxed in 3% glutaraldehyde,
0.1 M Na cacodylate (pH 7.4), 5 mM CaCl2, 5 mM MgCl2,
and 2.5% sucrose for 1 h. Cells were then washed in
100 mM Tris (pH 7.5), 25 mM DTT, 5 mM EDTA, and
1.2 M sorbitol for 10 min, and resuspended in 100 mM
K2HPO4 (pH 5.9), 100 mM citrate, and 1 M sorbitol. Fol-
lowing addition of oxylyticase (200 g/ml) and Zymolyase
T100 (600 g/ml), cells were incubated for 40 min at 30°C.
They were then spun down, washed, and resuspended in
cold buVer containing 500 mM Na cacodylate (pH 6.8) and
25 mM CaCl2, followed by osmium-thiocarbohydrazide
staining. Further processing details have been described
previously (Rieder et al. 1996).
Whole cell extracts and western blotting
Yeast whole cell extracts were prepared from 2 OD600 units
of cells by a mild alkaline treatment (Kushnirov 2000).
NIH-3T3 Wbroblasts were lysed in RIPA buVer (150 mM
NaCl, 1% NP40, 0.1% SDS, 1% deoxycholate, 50 mM
Tris–HCl pH 7.4) supplemented with a cocktail of protease
inhibitors (Complete, Roche) for 30 min at 4°C. Lysates
were then clariWed in a tabletop centrifuge. For the analysis
of eIF2 phosphorylation, equal amounts of protein from
diVerent extracts were resolved by SDS-PAGE and sub-
jected to western blotting using monospeciWc antibodies for
phosphorylated S51 in eIF2 (Biosource/44-718G) and
polyclonal antibodies that recognize total eIF2 (generous
gift from T. Dever).
Polysome analysis
Sucrose gradient analyses were performed according to de
la Cruz et al. (1997).
Northern blotting
Total RNA was extracted from 100 OD600 units of expo-
nentially growing cells and analyzed (5 g) by northern
blot as described (De Virgilio et al. 1993). DNA probes
were labeled with [¡32P]CTP using the PRIME-IT II Ran-
dom Primer Labeling Kit (Stratagene 300385).
35S pulse-chase assay and coimmunoprecipitation
Cell labeling was performed as described previously (Gaynor
and Emr 1997). BrieXy, mid-logarithmic phase (OD600 0.6)
cultures were concentrated to two OD600 units/ml and
Table 1 Yeast strains used in this study
Strain Genotype Source
BY4741 Mata his31 leu0 met150 ura30 De Virgilio’s lab
BY4742 Mat his31 leu0 met150 ura30 De Virgilio’s lab
SEY6210 Mata leu2-3,112 ura3-52 his3-200 trp1-901 lys2-801 suc2-9 Efe et al. (2005)
LC49 Mata leu2-3,112 ura3-52 his3-200 trp1-901 lys2-801 suc2-9 
GLN3::myc13-kanMX6
Cameroni et al. (2006)
ODY304 Mata leu2-3,112 ura3-52 his3-200 trp1-901 lys2-801 suc2-9 
sec7::SEC7-EGFPx3::URA3
This study
RSY101 Mat leu2-3,112 his3/4 kex2::URA3 Schekman’s lab
CY1100 MATa leu20 lys20 ura30 sui2::Kan / p[SUI2, LEU2 CEN] Cherkasova et al. (2003)
CY1101 MATa leu20 lys20 ura30 sui2::Kan / p[sui2S51A, LEU2 CEN] Cherkasova et al. (2003)
ODY197 MATa ura3-52 leu2-3l leu2-112 trp1-63::GCN4-LacZ::TRP1 
sui2 / pRS316[SUI2, URA3]
Deloche et al. (2004)
ODY198 MATa ura3-52 leu2-3l leu2-112 trp1-63::GCN4-LacZ::TRP1 
sui2 / pRS316[sui2-S51A, URA3]
Deloche et al. (2004)
H1647 Mat ura3-52 leu2-3 leu2-112 ino2 sui2 HIS4-lacZ ura3-52 /
p[SUI2, URA3]
Dever’s lab
ODY326 Mat ura3-52 leu2-3 leu2-112 ino2 sui2 HIS4-lacZ ura3-52 /
p[SUI2, LEU2 CEN]
This study
ODY327 Mat ura3-52 leu2-3 leu2-112 ino2 sui2 HIS4-lacZ ura3-52 / 
p[sui2S51A, LEU2 CEN]
This study
D665-1A MATa Prototrophic strain Rose et al. (1988)123
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Gene name CPZ Functions
10 M 20 M
Endosomal Golgi proteins 
SAC1 ¡ ¡ Phosphoinositide 4 phosphatase involved in protein traYcking
VPS1 ¡ ¡ Dynamin involved in Golgi/endosomal membrane traYcking
VPS54 ¡ ¡ Subunit of VFT complex involved in Golgi membrane traYcking
VPS52 ¡ ¡ Subunit of VFT complex involved in Golgi membrane traYcking
PEP5 ¡ ¡ Subunit of the HOPS complex involved in membrane fusion 
DRS2 +/¡ ¡ P-type aminophospholipid translocase involved in secretion
PEP12 +/¡ ¡ Endosomal t-SNARE involved in membrane fusion
APL2 +/¡ ¡ AP-1 complex subunit required in the formation of clathrin vesicles
KRE11 +/¡ ¡ Subunit of TRAPPII complex involved in Golgi membrane traYcking
SNF8 +/¡ ¡ Subunit of the endosomal protein sorting complex ESCRT-II
SNF7 +/¡ ¡ Subunit of the endosomal protein sorting complex ESCRT-III
VPS33 +/¡ ¡ Subunit of the HOPS complex involved in membrane fusion
RCY1 +/¡ ¡ F-box protein involved in protein recycling
VPS23 +/¡ +/¡ Subunit of the endosomal protein sorting complex ESCRT-I
VPS36 + +/¡ Subunit of the endosomal protein sorting complex ESCRT-II
VPS38 + +/¡ Part of the Vps34 PI3-kinase complex
MNN9 + +/¡ Alpha-1,6 mannosyltransferase of cis-Golgi compartment
KEX2 + +/¡ Endoproteinase of late-Golgi compartment
ER proteins
ERG2 +/¡ ¡ C-8 sterol isomerase
DER1 +/¡ ¡ Involved in degradation proteins 
Ribosomal components
RPS4A +/¡ +/¡ 40S ribosomal protein S4
TIF3 +/¡ +/¡ Translational initiation factor eIF4B
FUN12 +/¡ +/¡ General translation factor eIF2 homolog 
PTH +/¡ +/¡ Peptidyl-tRNA hydrolase 
MTQ2 +/¡ +/¡ S-adenosylmethionine-dependent methyl transferase
Transcription factor/nuclear proteins
CTK3 +/¡ ¡ Carboxy-terminal domain (CTD) kinase, gamma subunit
TAF14 +/¡ ¡ Transcription initiation factor TFIID/cellular morphogenesis
SAC3 +/¡ ¡ Leucine permease transcriptional regulator
THP1 +/¡ ¡ Nuclear pore associated protein
REF2 + +/¡ RNA 3-end formation protein
GCN5 + +/¡ Histone acetytransferase
RSC2 + +/¡ Part of the chromatin structure remodeling complex (RSC)
Metabolism—Kinase/phosphatase
SHP1 +/¡ ¡ Regulatory subunit for Glc7p phosphatase
CKB2 +/¡ ¡ Beta regulatory subunit of casein kinase 2
STA1 +/¡ ¡ Glucoamylase I (alpha¡1,4 glucan glucosidase)/periplasm
YSA1 +/¡ +/¡ Adenosine diphosphoribose pyrophosphatase
SIT4 +/¡ +/¡ Serine/threonine protein phosphatase
Ions transporters/chaperone
CCS1 +/¡ +/¡ Copper chaperone for superoxide dismutase Sod1p
SSQ1 + +/¡ Mitochondrial heat shock protein70
Polarized growth
SHE4 + +/¡ Required in actin organization and intracellular mRNA localization123
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Mix (Amersham Biosciences/AGQ0080) for 10 min in SD
medium containing 20 g/ml BSA. Cells were chased with
10 mM methionine, 4 mM cysteine and 0.4% yeast extract
for 20 min. To separate cells from media, cell suspensions
were centrifuged at 14,000g for 2 min. To assay [35S]
methionine/cysteine incorporation into proteins, whole cell
extracts were prepared by a mild alkaline treatment
(Kushnirov 2000). To determine secreted proteins, media
fractions were precipitated by addition of TCA to a Wnal
concentration of 10%. After washing the pellets twice in
cold acetone, proteins were solubilized in Laemmli sample
buVer plus 5% -mercaptoethanol. Labeling and immuno-
precipitation of secreted pro--factor were performed as
described (Seeger and Payne 1992). Labeled proteins and
labeled immunoprecipitated pro--factor were resolved on
SDS-PAGE gels and analyzed by Xuorography.
To label NIH-3T3 Wbroblasts, subconXuent dishes of
cells in DMEM supplemented with 10% FCS were pre-
treated with the indicated drugs for 10 min prior to a pulse
labeling period of 40 min with 50 Ci of Redivue™ PRO-
MIX™ Cell Labelling Mix. Cells were subsequently
washed two times with ice-cold PBS and lysed in RIPA
buVer. The lysate was clariWed in a tabletop centrifuge and
6 g of proteins were separated by SDS-PAGE and ana-
lyzed by Xuorography.
Fluorescence and indirect immunoXuorescence microscopy
For CPZ detection, cells were grown in YPD buVered at pH
8.0 with 20 mM Tris–HCl pH 9.4 to mid-logarithmic phase
at 30°C. For GFP images, ODY304 cells were grown in
SD-URA buVered at pH 8.0 with 20 mM Tris–HCL pH 8.0
to mid-logarithmic phase at 30°C and treated or not with
100 M CPZ for 30 min. Preparation of cells for immuno-
Xuorescence was essentially as described (Chuang and
Schekman 1996). Cells were grown to 0.8 OD600 units/ml
in SD medium at 30°C. Gln3p-myc13 was detected using
mouse -Myc (9B11, Cell Signaling) at a dilution of
1:2,000. Cy3 (indocarbocyamine)-conjugated goat anti-
mouse secondary antibodies (Jackson ImmunoResearch
Laboratories) were used at 1:2,000 dilution. Images (100£
magniWcation) were obtained using a Zeiss microscope
equipped with an Axiocam color digital camera and the
AxioVision™ software. Figures were prepared with the use
of the Adobe Photoshop 8.0 (Adobe Systems, San Jose,
CA, USA) software program.
-galactosidase assay
Cultures of cells containing the UPRE-LacZ plasmid (Zhou
and Schekman 1999), a genomic integrated GCN4-LacZ, or
HIS4-LacZ reporter were grown in synthetic complete
medium to early-logarithmic phase before drugs were
added for 2 h. UPR, Gcn4p and His4p expressions were
measured by a standard -galactosidase assay and the activ-
ity was normalized to the OD600 of cells (Miller Units) used
for each assay. All results are an average of at least three
independent determinations.
Results
CPZ prevents yeast cell growth and accumulates on internal 
membrane structures in a pH-dependent manner
CPZ is a permeable amphiphilic molecule that contains a
hydrophobic tricyclic ring and a hydrophilic dimethylpro-
pylamine side chain (Fig. 1a). The hydrophobic moiety
allows CPZ to intercalate and diVuse within the hydrocar-
bon phase of membrane bilayers. At physiological pH, the
tertiary dimethylpropylamine is protonated, creating a net
positive charge and leading to the accumulation of CPZ in
the cytosolic membrane leaXet by the formation of electro-
static interactions with anionic lipids such as phosphatidyl-
serine (PS), phosphatidylamine (PA) and phosphoinositides
(PIs) (Fig. 1b) (Chen et al. 2003; Jutila et al. 2001; Sheetz
and Singer 1974). To investigate the toxic membrane
eVects of CPZ on actively growing yeast cells, we spotted a
wild-type culture grown to exponential phase on rich
medium (YPD) plates containing increasing concentrations
of CPZ, at diVerent pH (Fig. 1c). We found that the mini-
mal concentration of CPZ required to block growth is
30 M at pH 8, and that lowering the pH results in
Table 2 continued
(+), (+/¡) and (¡) indicate normal, slow or no growth phenotype, respectively. All strains are isogenic to the parental BY4741, a derivative of
S288C strain background
Gene name CPZ Functions
10 M 20 M
Proteins with unknown functions
YLR169W + +/¡
YHR210C + +/¡ Similarity to UDP-glucose-4-epimerase
YLR169W + +/¡123
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longer aVected by 60 M of CPZ. These data corroborate
the previously observed pH-dependent eVects of CPZ on
erythrocyte membranes (Ahyayauch et al. 2003), and might
be explained by the fact that positively charged CPZ is
unable to enter the cells and diVuse within membranes. To
test this possibility further, we took advantage of the fact
that CPZ Xuorescence intensity increases when interacting
with anionic lipids (Chen et al. 2003), which allows it to be
visualized within cells. As expected, no intracellular Xuo-
rescence was detected at acidic pH (Fig. 1d), conWrming
that protonated CPZ cannot cross the plasma membrane
bilayer. At pH 8, CPZ diVuses within the cell and partitions
into visible membrane structures, which are reminiscent of
the ER and vacuole compartments (data not shown). Fur-
thermore, the presence of bright spots of Xuorescence in the
interior of cells (Fig. 1d) suggests that CPZ is protonated in
the cytosol, allowing its binding to anionic lipids present on
the cytosolic face of subcellular compartments. We there-
fore propose that the insertion of CPZ into the cytosolic
membrane bilayer of internal organelles alters essential cel-
lular growth activity.
A genome-wide screen reveals that mutants displaying
a transport defect between late-Golgi and endosomal 
compartments are CPZ-hypersensitive
To gain a better insight into the biological eVects of CPZ on
yeast membranes, we next performed a genome-wide
screen for CPZ-hypersensitivity. In analogy to the principle
of the synthetic lethal screen (HuVaker et al. 1987), CPZ-
hypersensitive mutants are likely to deWne essential biolog-
ical functions that also are targeted by CPZ. For this screen,
a collection of yeast deletion strains (4,857 knockout
mutants) was replicated on YPD plates at pH 8.0 containing
either no drug or two diVerent sub-lethal concentrations of
CPZ and grown for two days at 30°C. The genes identiWed
as essential for normal growth in the presence of CPZ are
listed in diVerent functional categories in the Table 2. Inter-
estingly, the most CPZ-sensitive strains bear mutations that
directly perturb membrane and protein traYcking between
the late-Golgi and endosomal compartments. Among the
genes identiWed, SAC1 encodes a phosphoinositol-4-phos-
phatase that regulates membrane and cytoskeleton function
(Foti et al. 2001; Schorr et al. 2001). In this respect, it is
noteworthy that CPZ increases the steady state level of PI4-
P (phosphate at the D-4 position of the inositol ring) in
human platelets and in mice Wbroblasts (Frolich et al. 1992;
Raucher and Sheetz 2001). PIs, but also PA and phosphati-
dylethanolamine (PE), which serve as a lipid platform for
the recruitment of coat proteins and promote membrane
curvature to initiate the formation of vesicles (Bankaitis
et al. 1990; Ktistakis et al. 1996; Rothman and Wieland
1996), are potential CPZ binding sites. Thus, it is likely that
CPZ, by interacting with negatively charged lipids, inter-
feres with membrane transport and produces a synergistic
growth defect when combined with mutants that block
membrane traYcking between the late-Golgi and endoso-
mal compartments.
CPZ alters membrane structures of internal organelles 
and blocks the secretory pathways
To determine whether CPZ alters Golgi functions by interfer-
ing with the binding of proteins to Golgi membranes, we
used a wild-type strain expressing a Sec7p-GFP fusion pro-
tein. Sec7p is an abundant peripheral membrane protein of
the late Golgi, which is involved in vesicular membrane
traYcking (FranzusoV et al. 1992). Under normal growth
conditions, the Sec7p-GFP Xuorescence was detected in
Fig. 1 The insertion of CPZ into membrane bilayers aVects yeast via-
bility. a Chemical structure of CPZ. b Schematic representation show-
ing the interaction of CPZ with negatively charged lipids. The
hydrophobic nature of CPZ promotes its association with and diVusion
within the lipid bilayer membrane. When exposed to the cytosol, CPZ
is protonated and accumulates in the inner leaXet of membranes by the
formation of electrostatic interactions with anionic phospholipids. This
model is based on data published by Chen et al. (2003). c The toxicity
of CPZ is pH dependent. Equivalent numbers of wild-type cells
(SEY6210) were serially diluted and spotted onto YPD plates contain-
ing 0, 30 and 60 M of CPZ at pH 3, 6 or 8. d The accumulation of CPZ
within the cells occurs only at high pH. SEY6210 (wild-type) cells
were incubated with CPZ (100 M) for 30 min at pH 3 or 8. CPZ Xu-
orescence emission was then detected by microscopy (UV excitation
DAPI/365 nm). Cells were observed by diVerential interference optics
(DIC)123
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presence of 100 M CPZ, the Xuorescence was more diVused
throughout the cells, revealing a lower capacity of Sec7p to
bind to Golgi membranes, and as a consequence, to regulate
membrane traYcking. Since defects of membrane transport
through the late-Golgi and endosomal compartments often
lead to a marked distortion of organelles of the secretory
pathway, we next examined CPZ-treated cells by electron
microscopy analysis. Ultrastructural analysis (Fig. 2b)
revealed that cells treated with CPZ accumulate enlarged ER,
Berkeley bodies [membrane structures that were initially
observed in mutants defective in Golgi transport (Novick
et al. 1980)], as well as membrane inclusions and other unde-
Wned aberrant membrane structures. Additionally, vacuoles
were also larger and less electron dense, suggesting an eVect
of CPZ on vacuolar membrane permeability. Another strik-
ing morphology change was the formation of small blebs on
the plasma membrane, which likely result from a decrease in
plasma membrane–cytoskeleton adhesion (Raucher and
Sheetz 2001). Finally, high concentrations of CPZ cause for-
mation of micelles (data not shown), which were visualized
by Xuorescence (Fig. 1d). Collectively, these observations
further support that an important deregulation of membrane
transport occurs after CPZ treatment and prompted us to
investigate the eVect of CPZ on the secretory pathway. To do
this, we took advantage of the fact that yeast cells eYciently
secrete a few proteins into the growth medium (Robinson
et al. 1988). Wild-type cells were incubated with or without
CPZ for 10 min at 30°C, labeled with [35S]-methionine/cys-
teine for 10 min (pulse) and chased for 20 min. Cells and
media were separated by centrifugation and proteins in the
media were precipitated with TCA and resolved by SDS-
PAGE. The incorporation of [35S]-methionine/cysteine into
proteins was reduced in cells incubated with CPZ, indicating
that CPZ causes a general inhibition of protein synthesis
(Fig. 3a). Protein secretion was severely aVected, with only
one abundant protein (migrating in the molecular weight
range of the secreted Hsp150p) detected in media of cultures
treated with 100 M CPZ (Fig. 3b) (Gaynor and Emr 1997;
Russo et al. 1992). In addition, under the same growth condi-
tion, the newly synthesized precursor forms of the -factor
pheromone that are normally secreted from cells lacking the
endoprotease Kex2p (Fuller et al. 1988; Julius et al. 1984)
were not immunoprecipitated from media using -factor pre-
cursor antiserum (Fig. 3c), which further conWrms a secretory
transport defect in cells treated with CPZ.
CPZ induces the UPR pathway and GCN4 mRNA 
translation
To alleviate a secretory stress, cells activate the UPR path-
way that leads to the expression of speciWc genes, whose
products promote stress adaptation thereby allowing cells
to grow. We next tested whether the UPR is activated in
CPZ-treated cells. Activation of the UPR was assayed by -
galactosidase activity (Fig. 4a) using an UPRE-lacZ
reporter gene transformed in wild-type cells. As expected,
cells treated with tunicamycin (Tm), which blocks N-pro-
tein glycosylation and elicits the UPR, exhibit elevated
UPRE expression (5.8-fold increase). Treatment with
30 M CPZ, a concentration that slightly aVects protein
synthesis (data not shown), results in a 2.7-fold increase of
-galactosidase activity, indicating that CPZ activates the
UPR pathway at this concentration. At 100 M CPZ, the
UPR was slightly lower, a result that might be explained by
Fig. 2 CPZ perturbs membrane structures a CPZ reduces the binding
aYnity of Sec7-GFP to late-Golgi membrane. ODY304 (SEC7-GFP)
cells were grown to mid-logarithmic phase at 30°C, treated or not with
CPZ (100 M) for 30 min and processed for Xuorescence microscopy.
Cells were observed by diVerential interference optics (DIC). Images
shown are representative of more than 100 cells observed. b, c EM
analysis of subcellular structure in CPZ-treated cells. SEY6210 (wild-
type) cells were grown to mid-logarithmic phase at 30°C (non-treated
b) and CPZ (100 M) was added for 40 min c. Cells were subsequently
processed and visualized by EM as described in Materials and meth-
ods. Black arrowheads indicate the presence of plasma membrane
blebs. Vacuoles (V), nuclei (N), endoplasmic reticulum (ER), berkeley
bodies are also indicated123
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GCN4 transcription. We previously showed that a CPZ
treatment causes a rapid phosphorylation of eIF2 (Deloche
et al. 2004). In accord with this observation and with the
role of eIF2 in the activation of GCN4, we showed that
30 M CPZ leads to a 3.1-fold increase of the -galactosi-
dase activity in cells containing the GCN4-lacZ reporter
(Fig. 4b). Importantly, as in rapamycin-treated cells, CPZ-
induced GCN4 expression depends on eIF2 phosphoryla-
tion, since no increase of the -galactosidase activity was
observed in cells expressing the non-phosphorylated
eIF2aS51A (in a sui2-S51A mutant). Additionally, it is worth
noting that UPRE expression is also signiWcantly reduced
in the sui2-S51A mutant upon an ER stress (Fig. 4a), which
corroborates the previous Wnding that Gcn4p expression
plays a major role in the UPR activation (Patil et al. 2004).
Altogether, these results demonstrate that cells upregulate a
subset of stress genes in response to a mild CPZ treatment.
The transcription of the HIS4 gene is known to be upregu-
lated by Gcn4p under conditions of amino acid starvation
(Drysdale et al. 1995). We thus determined whether Gcn4p
induced by CPZ increases the -galactosidase activity in
cells containing the HIS4-lacZ reporter. As shown in
Fig. 4c, the HIS4-lacZ is not derepressed under conditions
where GCN4-lacZ activity is induced by CPZ. In contrast,
the addition of 3-aminotriazole (3-AT; an inhibitor of histi-
dine biosynthesis) increased HIS4-lacZ activity in an eIF2
phosphorylation-dependent manner. This Wnding strength-
ens previous results showing that the expression of Gcn4p
is not only dedicated to the control of amino acid biosyn-
thesis (Natarajan et al. 2001). Notably Gcn4p also regulates
gene products involved in degradation of autophagosomes
in a process known as autophagy (Klionsky and Emr 2000).
In this context, a recent study (SteVensen and Pedersen
2006) reported that induction of heterologous membrane
protein production derepresses Gcn4p without increasing
transcription of HIS4. Under these conditions, Gcn4p may
stimulate expression of genes whose products are involved
in autophagy, thereby contributing to the degradation of
excess of useless and/or toxic proteins. It is likely that CPZ
causes mis-localization of a large number of membrane
proteins by aVecting membrane structures and vesicular
traYcking. Thus, by analogy, the increase of Gcn4p follow-
ing CPZ treatment may induce transcription of both auto-
phagy and UPR genes (see also Discussion). This
transcriptional response would serve to alleviate cellular
stress by increasing the degradation rate of mis-localized
membrane proteins and by restoring membrane transport
along the biosynthetic pathways.
Inhibition of translation initiation occurs in a prototrophic 
strain and does not result from TORC1 inactivation
As observed by others (Cherkasova and Hinnebusch 2003),
we detected an increase of eIF2 phosphorylation in cells
treated with 10 g/ml Tm. Our data however suggest that
the UPR pathway does not mediate this increase, since we
observed that UPR-deWcient mutants (hac1 and ire1;
data not shown) show a similar eIF2 phosphorylation level
as wild-type cells when treated with Tm. This Wnding sug-
gests that eIF2 phosphorylation does not result from the
ER stress, but possibly indirectly from a defective mem-
brane transport event along the secretory pathway. One
hypothesis would be that CPZ inhibits translation initiation
by altering the subcellular localization and/or the activity of
amino acid transporters, which could then lead to a rapid
depletion of the intracellular amino acid pool. For instance,
the volatile anesthetic isoXurane was previously shown to
induce the phosphorylation of eIF2 by inhibiting the
import of some amino acids in auxotrophic strains (Palmer
et al. 2002). To address this possibility, we tested the eVect
of CPZ on eIF2 phosphorylation and translation initiation
in the prototrophic strain D665-1A (Fig. 5a). As observed
in SEY6210 (auxotroph), eIF2 was also phosphorylated in
D665-1A after 30 min of 30 M CPZ treatment (Fig. 5b).
Accumulation of the 80S monosome and decrease of poly-
some content were also evident (Fig. 5c), corroborating a
translation initiation defect. Higher concentrations of CPZ
led to an even greater translation defect with a higher level
of eIF2-P. At 200 M CPZ, protein synthesis was totally
blocked as judged by the lack of actively translating ribo-
somes (Fig. 5c). Interestingly, a signiWcant increase of the
Fig. 3 CPZ blocks the secretory pathways. a, b SEY6210 (wild-type)
cells were incubated at 30°C with the indicated concentration of CPZ
(0, 30 or 100 M) for 10 min before being metabolically [35S]-labeled
for 10 min and chased for 20 min. Cells and media were separated by
centrifugation and protein secreted in media during the pulse-chase
were precipitated with 10% TCA. The incorporation of [35S] methio-
nine/cysteine into proteins from cells after 10 min of pulse a and se-
creted [35S]-proteins from media after 0 or 20 min of chase b were
visualized by SDS-PAGE and Xuorography. c RSY101 (kex2) cells
were metabolically [35S]-labeled as described in a and b. After 0 or
20 min of chase, the pro--factor was immunoprecipitated from media
using rabbit polyclonal pro--factor antibody and detected by SDS-
PAGE and Xuorography
0 20 0 20 0 20 min0 30 100 µM
Secreted proteins Secreted pro-α-factor
0 20 0 20 0 20 min
0 30 100 µM 0 30 100 µM
Incorporation
A B C123
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thesis or the stability of the 60S subunit is aVected. These
data are reminiscent of previous studies of the group of J.
R. Warner, who showed a close relationship between the
secretory pathway and ribosome biogenesis (Mizuta and
Warner 1994) and a transcriptional repression of ribosomal
protein genes upon a CPZ treatment at 250 M (Nierras and
Warner 1999).
TORC1 (Target Of Rapamycin Complex 1) controls the
activity of Gcn2p in response to cellular nutrient availabil-
ity (Cherkasova and Hinnebusch 2003) and associates
with membrane endocytic elements (Chen and Kaiser
2003). This raised the possibility that CPZ might inacti-
vate TOR activity by altering the localization and/or the
lipid environment of TOR proteins. To address this possi-
bility, we examined whether CPZ changes the expression
of speciWc genes or the levels of glycogen, which are
under the control of TORC1. Gln3p is the transcription
activator of nitrogen catabolic genes, which is translocated
into the nucleus under low nitrogen conditions or in
response to TORC1 inhibition by rapamycin (Beck and
Hall 1999). A wild type strain containing a genomically
integrated myc-tagged GLN3 allele was treated with CPZ
(100 M) or rapamycin (1 g/ml; »1 M) for 30 min and
60 min (data not shown) and Gln3p localization was visu-
alized by indirect immunoXuorescence. As shown in
Fig. 6a, Gln3p is found throughout the cytoplasm of CPZ-
treated cells, while in control experiments, rapamycin
caused a strong accumulation of Gln3p in the nucleus. We
next measured the mRNA levels of HSP26 and GLN1,
which are normally derepressed in rapamycin-treated cells
(Fig. 6b). At 30 M, a concentration of CPZ that inhibits
ribosome biosynthesis (as judged by the decrease of the
mRNA levels of RPS12 and the ribosome-associated heat
shock protein SSB1), the expression of GLN1 and HSP26
genes remains still repressed. At a higher concentration of
CPZ (100 M), a slight induction of GLN1 after 30 min
and HSP26 after 60 min was detected, suggesting that
TORC1 might be partially inactivated under this condi-
tion. Finally, almost no glycogen accumulates in CPZ-
treated cells as compared to cells treated with rapamycin
(Fig. 6c). Taken together, our results indicate that, at least
at concentrations of CPZ below 100 M, inhibition of pro-
tein synthesis following CPZ treatment does not result
from inhibition of an amino acid permease and/or TORC1
inactivation.
CPZ increases the phosphorylation of eIF2 and inhibits 
protein synthesis in NIH-3T3 cells
Previously, CPZ was shown to block clathrin-mediated
endocytosis and the recycling of LDL receptor to the cell
surface in human Wbroblast cells (Wang et al. 1993).
These data prompted us to determine whether a mem-
brane transport defect induced by CPZ also results in a
rapid inhibition of protein synthesis in mammalian cells.
We used mice Wbroblast NIH-3T3 cells that have previ-
ously been studied under conditions of CPZ treatment
(Raucher and Sheetz 2001). As in yeast cells (Fig. 1a),
CPZ traverses the plasma membrane and accumulates at
the interior of the cell, potentially by interacting with
internal membranes (Fig. 7a). To determine if CPZ inhib-
Fig. 4 CPZ activates the UPR pathway and GCN4 expression. a
CY1100 (SUI2) and CY1101 (sui2-S51A) strains were transformed
with a reporter plasmid (CEN, URA3) carrying the UPRE-LacZ con-
struct and grown in SD medium at 30°C to mid-logarithmic phase. b
ODY197 (SUI2) and ODY198 (sui2-S51A) containing a genomic inte-
grated GCN4-lacZ reporter and c ODY326 (SUI2) and ODY327 (sui2-
S51A) containing a genomic integrated HIS4-lacZ reporter were
grown as described in a. Tunicamycin (Tm  10 g/ml), Rapamycin
(Rap  1 g/ml), 3-aminotriazole (3-AT 10 mM) or CPZ (10, 30 or
100 M) were added for 2 h as indicated. The levels of -galactosidase
activity were measured as described in Materials and methods. The re-
sults shown are from an average of at least three independent determi-
nations. Black bars are cells containing the SUI2 allele and white bars
are cells containing the sui2-S51A mutant allele
A B C123
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of [35S]-methionine/cysteine in CPZ-treated NIH-3T3
cells (Fig. 7b). At 30 M concentration, almost no radio-
labeled proteins were detected, indicating that CPZ rap-
idly blocks mRNA translation. Notably, under this
condition, the uptake of radiolabeled amino acids into
cells was not aVected (data not shown). Importantly, this
inhibition was associated with an increase in eIF2 phos-
phorylation, similarly as in cells exposed to either thapsi-
gargin, dithiothreitol or Tm; all agents that are known to
induce an ER stress and to inhibit protein synthesis by
activating the ER-localized eIF2 kinase PERK (Fig. 7b)
(Harding et al. 2000). Altogether these results reveal that
the relationship between membrane stress and translation
initiation might be conserved from yeast to mammalian
cells.
Fig. 5 Translational inhibition also occurs in a CPZ-treated prototro-
phic strain. a The prototrophic strain (D665-1A) grows in medium
lacking amino acids. SEY6210 (auxotroph) and D665-1A (prototroph)
cells were serially diluted and spotted onto YPD or SD-AA plates and
incubated for 2 days at 30°C. b CPZ induces the phosphorylation of
eIF2 in the prototrophic strain. SEY6210 (auxotroph) and D665-1A
(prototroph) cells were grown to mid-logarithmic phase at 30°C in
YPD and CPZ was added for 30 min at the indicated concentration.
Whole cell extracts were prepared and phosphorylation of eIF2 (S51)
was compared with the total amount of eIF2 protein determined by
western analysis. c CPZ alters the polysome proWle in the prototrophic
strain. D665–1A (prototroph) cells were grown in YPD at 30°C to mid-
logarithmic phase, split and the indicated concentration of CPZ was
added to cultures for 45 min. Cells were then harvested and polysomes
were analyzed. The positions corresponding to the 40S, 60S subunits,
80S monosomes and polysomal ribosomes are indicated
YPD SD-AA
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Fig. 6 TORC1-dependent signaling pathways are not aVected in CPZ-
treated cells. a LC49 (GLN3::myc13) strain expressing genomically
tagged Gln3p-myc13 were grown in YPD and treated with CPZ
(100 M) or rapamycin (Rap 1 g/ml). Gln3p-myc13 was visualized
by immunoXuorescence using monoclonal anti-Myc antibody and
DNA was stained with DAPI. b SEY6210 (wild-type) was grown as in
a and treated with CPZ (30 or 100 M). At the indicated times, cells
were harvested and northern analysis of indicated genes was performed
as described in Materials and methods. c Glycogen accumulation was
visualized after exposure for 1 min to iodine vapor (Dubouloz et al.
2005) on exponentially growing SEY6210 (wild-type) cells, treated or
not with rapamycin (Rap 200 ng/ml) or CPZ (10, 30 or 100 M) for 4 h
RPS12
GLN1
HSP26
SSB1
18S
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CPZ perturbs internal membrane structures and protein 
transports
CPZ is a permeable amphiphilic molecule that partitions
into the lipid cytoplasmic half of the membrane bilayer by
interacting with the polar headgroups of phospholipids,
resulting in the deformation of membrane structures. In the
present study, we investigated the eVects of CPZ on yeast
membranes and demonstrate that CPZ diVuses within the
cells and deforms membranes of intracellular organelles.
Because negatively charged lipids such as PI, PA and PE
localized on Golgi and endosmal compartments are known
to induce membrane curvatures and recruit coat proteins to
initiate the formation of vesicles, we argue that CPZ inhib-
its intracellular traYcking by modifying the structure and
the net charges of membranes on secretory/endocytic com-
partments. Consistent with this idea, we showed that CPZ
prevents the binding of Sec7p, an essential protein for
secretion, onto late-Golgi membranes and rapidly blocks
transport of some secreted proteins. Furthermore, our CPZ
genetic screening analysis on the entire knockout gene
mutant library revealed that the most CPZ-sensitive strains
are those bearing mutations that alter membrane and pro-
tein traYcking between the late-Golgi and endosomal com-
partments.
CPZ-mediated stress leads to the expression of UPR genes 
and of Gcn4p, but does not inactivate TORC1 activity
Like most mutants experiencing a partial membrane trans-
port defect (Chang et al. 2004), CPZ activates UPR gene
expression. This transcriptional response is required for a
rapid cellular adaptation in response to a membrane trans-
port defect (Chang et al. 2004). The UPR integrates the
Gcn4p-dependent cytosolic stress response (Patil et al.
2004). In this context, CPZ also induces GCN4 expression.
Translational induction of GCN4 is part of the cellular
response to changes in the environment such as depletion of
amino acids (Natarajan et al. 2001). In CPZ-treated cells,
the expression of Gcn4p depends on the Gcn2p-stimulated
eIF2 phosphorylation. Since the only known way to acti-
vate Gcn2p is through binding of uncharged tRNA to its
histidyl-tRNA-like domain, we Wrst hypothesized that CPZ
reduces the cytoplasmic levels of amino acids by decreas-
ing the activity of amino acid transporters. Our data showed
the phosphorylation of eIF2 still occurs in a prototrophic
strain, indicating that CPZ does not block the import of
amino acids. Nevertheless, we next reasoned that CPZ
might reduce the activity of amino acid transporters local-
ized on internal organelles such as the vacuoles (principal
cellular amino acid storage). This might cause a decrease of
the intracellular amino acid concentration, specially since
the vacuolar membrane permeability appears to be aVected
by CPZ (Fig. 2b). However, none of the tested TORC1
readouts, which are normally induced under amino acid
starvation, were signiWcantly changed after CPZ treatments
at concentration that induce Gcn4p expression. Further-
more, CPZ does not induce HIS4 transcription, which is
normally activated by Gcn4p under conditions of amino
acid starvation. These results indicate that CPZ-treated cells
do not seem to respond to a particular nutrient limitation
Fig. 7 CPZ inhibits protein synthesis and induces the phosphorylation
of eIF2 in NIH-3T3 Wbroblasts. a A Xuorescent picture of CPZ-treat-
ed NIH-3T3 Wbroblasts. NIH-3T3 Wbroblasts were incubated with
100 M CPZ for 30 min and Xuorescence was visualized by micros-
copy as in Fig. 1c. b Protein synthesis rates were measured by the
incorporation of [35S] methionine/cysteine into proteins. NIH-3T3
Wbroblasts were incubated with either 10 or 30 M CPZ, 1 M thapsin-
gargin (Tg), 2 mM DTT or 10 g/ml tunicamycin (Tm) for 10 min pri-
or to a 40 min pulse labeling period. The labeled proteins in a whole
cell extract were resolved by SDS-PAGE and Xuorography (upper
panel). Phosphorylation of eIF2, from the same extracts, was detected
by western analysis and compared with the total amount of eIF2 pro-
tein and shown in the lower panel
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situation.
We recently showed that a decrease of phosphatidyl ino-
sitol 4-phosphate (PI4-P) levels on Golgi and ER organelles
in a pik1 (PI4-kinase) mutant result in a rapid phosphoryla-
tion of eIF2 (Cameroni et al. 2006). Like sac1 and drs2
mutants that deregulate the net charge of phospholipids on
Golgi/endosomal compartments (see Table 1), the pik1
temperature sensitive mutant is highly sensitive to CPZ at
permissive temperature (data not shown). Thus, it is possi-
ble that CPZ induces eIF2 phosphorylation by interfering
with the function of charged lipids such as PI4-P. PI4-Ps
are essential for protein transport from the Golgi apparatus
to the plasma membrane. However, because some sec
mutants do not induce phosphorylation of eIF2 (e.g., sec4;
Deloche et al. 2004), a block of protein transport to the cell
surface does not seem to be directly linked to phosphoryla-
tion of eIF2. Additionally, the activation of UPR does not
induce eIF2 phoshorylation (data not shown) and GCN4
mRNA translation (SteVensen and Pedersen 2006), demon-
strating that Gcn2p is not stimulated by an ER stress. How
eIF2 phosphorylation is induced in CPZ-treated cells
remains unclear. If CPZ does not perturb the intracellular
level of amino acids nor inhibit TORC1, it is unlikely to
impinge on Gcn2p activity. Alternatively, CPZ may, via its
interaction with speciWc phospholipids on intracellular
organelles, disturb the activity of an eIF2-P-targeting
phosphatase(s) (Fig. 8). Notably, the type I phosphatase
Glc7p that regulates homotopic vacuole fusion, ER to
Golgi and endocytic transports (Peters et al. 1999), and
modulates the level of eIF2 phosphorylation (Wek et al.
1992) might be (indirectly) inhibited by CPZ, thereby lead-
ing to a rapid increase of eIF2-P. Accordingly, Gcn4p
derepression in CPZ-treated cells may be a physiological
response that is necessary to modulate UPR gene expres-
sion in a coordinated manner with Hac1p (Fig. 8) to allevi-
ate a membrane transport defect. However, in contrast to
Patil et al. (2004), we found that activation of the UPR does
not exclusively depend on the expression of Gcn4p since
UPR activation following Tm or CPZ treatment was not
abolished neither in the sui2-S51A mutant (Fig. 4a) nor in
gcn2 and gcn4 strains (data not shown). One explana-
tion for this discrepancy is that we used a higher concentra-
tion of Tm (10 vs. 1 g/ml), which may perturb the
secretory pathway. In this regard, a block of the secretory
pathway was shown to boost HAC1 mRNA abundance
(Leber et al. 2004) that, upon splicing, yields a higher pro-
duction of Hac1p (S-UPR; see Introduction). It is therefore
possible that an increased concentration of Hac1p, induced
by a distal secretory stress from the ER, bypasses the
requirement of Gcn4p to increase the UPR. Accordingly,
Gcn4p may be mainly required in the early stage of the
UPR, during a period where the cellular concentration of
Hac1p is low (see also Fig. 4 in Patil et al. 2004). Alterna-
tively, a secretion defect might induce additional regulatory
factors that are capable of modulating the activity of
Hac1p, thereby contributing to upregulation of UPR genes
in the absence of Gcn4p.
CPZ rapidly inhibits protein synthesis by acting on multiple 
translation factors
The rapid increase of eIF2 phosphorylation in CPZ-treated
cells argues that membrane stress is intimately connected to
the control of translation initiation. At 100 M, CPZ
induces a much higher level of eIF2 phosporylation than
at 30 M, a concentration that was suYcient to totally dere-
press GCN4. The hyperphosphorylation of eIF2 was
shown to cause a decrease in overall protein synthesis
Fig. 8 Schematic representation of pathways controlling protein syn-
thesis in response to a CPZ-stressed membrane treatment. The control
of protein synthesis can be divided in two steps. The Wrst step occurs
after a mild membrane stress (secretory pathway is not blocked) and
leads to the expression of speciWc genes under the control of the tran-
scription factors Hac1p and Gcn4p. Crosstalk between Hac1p and
Gcn4p to upregulate a subset of UPR genes may exist as described (Pa-
til et al. 2004). The second step occurs after a more severe membrane
stress and leads to the inhibition of protein synthesis. Highly phosphor-
ylated eIF2 and the 4E-binding protein Eap1p reduce overall mRNA
translation initiation. We do not exclude that other factors inhibit trans-
lation initiation (see text). Finally, a complete block of the secretory
pathway leads to a drastic decrease in ribosome biogenesis, resulting in
a more severe protein synthesis inhibition. This regulation might be
mediated by the cell wall integrity (PKC1) pathway as described in sec
mutants (Nierras and Warner 1999). Arrows and bars denote positive
and negative interactions, respectively. Solid arrows and bars refer to
direct and/or conWrmed interactions, dashed arrows and bars refer to
indirect and/or potential interactions. Black circles containing the letter
P denote phosphorylated amino-acid residues. UPR Unfolded protein
response; TORC1 TOR complex 1; AA amino acids; PPase phospha-
tase. See text for further details
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lular resources. We have shown previously that this inhibi-
tion of translation initiation is not completely abrogated in a
mutant strain where eIF2 cannot be phosphorylated
(eIF2-S51A), implying the existence of additional mecha-
nisms of translation inhibition (Deloche et al. 2004). Nota-
bly, we reported that the eIF4E-binding protein Eap1p
functions as a translation initiation inhibitor in cells treated
with CPZ and in mutants that block secretory or endocytic
pathways (e.g., sec4 and end3). Interestingly, Eap1p was
shown to interact genetically and biochemically with
Scp160p (Mendelsohn et al. 2003), a ribosomal protein
localized to the endoplasmic reticulum (Frey et al. 2001). It
will be thus interesting to determine if Eap1p is essentially
dedicated to the control of the expression of genes whose
products are transported along the secretory pathway.
Finally, we cannot exclude that other translation factors
such as eIF4B (i.e, Tif3p) also play a role in signaling the
translation inhibition response after a membrane stress.
eIF4B is an RNA-binding protein that stimulates eIF4A
helicase activity to enhance the unwinding of inhibitory
secondary structures in the 5 untranslated region of
mRNAs. Interestingly, the eIF4B deletion strain was found
to be highly sensitive to rapamycin, an observation that cor-
roborates the Wnding that the mammalian eIF4B is an indi-
rect target of mTOR, which is responsive to amino acid
starvation (Raught et al. 2004). In this regard, we previ-
ously observed that the eIF4B mutant is synthetically lethal
with mutants that aVect Golgi function (e.g., vps54,
mon2 (Deloche et al. 2004)) and is partially sensitive to
CPZ (Table 1), indicating that the function of eIF4B is
required for cell growth during a membrane (Stevens et al.
1986) stress. Finally, at 200 M CPZ, the level of ribo-
somal subunits dramatically dropped, resulting in a total
arrest of protein synthesis (Fig. 8). This result conWrms that
CPZ, at concentrations that totally block the membrane and
protein traYcking processes, represses ribosomal protein
(RP) gene transcription (Nierras and Warner 1999), and
substantiates the existence of an intimate coordination
between ribosome biosynthesis and secretion (Mizuta and
Warner 1994). Altogether our results suggest that distinct
regulatory pathways inhibit protein synthesis, by targeting
multiple translation factors in response to a severe mem-
brane stress.
In this study, we also showed that CPZ strongly inhibits
protein synthesis in mammalian cells. Remarkably, this
inhibition is also coupled to a rapid phosphorylation of
eIF2. Thus, mammals appear to possess a similar adaptive
response pathway, capable of integrating membrane stress
to regulate translation initiation. We believe that the control
of the phosphorylation of eIF2 may directly result from
UPR activation. In contrast to yeast, higher eukaryotes pos-
sess a ER-resident transmembrane kinase, PERK, that
phosphorylates eIF2 upon abnormal accumulation of
unfolded proteins. Accordingly, CPZ might impair ER
functions by altering membranes of secretory organelles,
leading to a rapid inhibition of translation via the activation
of PERK. This translation inhibition is likely independent
of Gcn2p and might explain why protein synthesis is more
eYciently inhibited by CPZ in NIH-3T3 Wbroblasts than in
yeast cells (data not shown).
In conclusion, we reported that CPZ, one of the most
common drugs used for people with schizophrenia world-
wide alters the integrity of most membrane organelles
within a cell. Our results demonstrate that membrane stress
induced by CPZ leads to a rapid translational control mech-
anism mainly mediated by the highly conserved eIF2
translation factor.
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